Concord Medical Services Holdings Limited (NYSE:CCM) has been given a consensus broker rating score of 3.70 (Sell) from the one brokers that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a sell recommendation.

Brokers have set a twelve-month consensus price objective of $3.00 for the company, according to Zacks. Zacks has also given Concord Medical Services an industry rank of 233 out of 265 based on the ratings given to related companies.

Separately, Zacks Investment Research upgraded Concord Medical Services from a “hold” rating to a “buy” rating and set a $4.50 price target for the company in a research report on Monday, July 31st.

A hedge fund recently raised its stake in Concord Medical Services stock. Renaissance Technologies LLC lifted its stake in Concord Medical Services Holdings Limited (NYSE:CCM) by 48.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 199,100 shares of the company’s stock after purchasing an additional 64,600 shares during the quarter. Renaissance Technologies LLC owned 1.37% of Concord Medical Services worth $940,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 12.28% of the company’s stock.

Concord Medical Services (NYSE CCM) opened at $3.95 on Tuesday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.59 and a current ratio of 1.60. Concord Medical Services has a 1 year low of $3.22 and a 1 year high of $4.96.

COPYRIGHT VIOLATION NOTICE: This piece was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/11/28/concord-medical-services-holdings-limited-ccm-given-3-00-average-price-target-by-brokerages.html.

About Concord Medical Services

Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China.

Get a free copy of the Zacks research report on Concord Medical Services (CCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Concord Medical Services Holdings Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services Holdings Limited and related companies with MarketBeat.com's FREE daily email newsletter.